A Ukrainian-American early-stage venture firm founded in 2021 that invests $50,000–$200,000 in Ukrainian and CEE-founded startups expanding into US and EU markets.
Founded —
Type Venture capital 2 ZAS Ventures Fund II, LP 2026-02-26 2026-02-26 — SEC Form D signed/filed 2026-02-26: USD 15000000 offering target; USD 1420000 sold; USD 13580000 remaining; 8 investors. Formed 2025; first sale 2026-02-14. Dated regulatory amounts only; final close/current size unverified.
ZAS Ventures Fund I, LP 2025-07-07 2025-07-07 — SEC amendment signed 2025-07-07: USD 3331818 offered and sold, zero remaining, 39 investors. Formed 2021; first sale 2023-07-07. Fully sold regulatory offering is not audited AUM or a verified final-close announcement.
SHOW MORE
— — – — — — – — — — – — — — – — — — – — — — – — — — – —
SHOW MORE
No co-investors on record yet.
team@apexlogos.ai · 12 hours ago
Investment-fund research reviewed 2026-10-06. Publicly identified funds, dates, amounts and fundraising status are below. Undisclosed commitments remain unknown; this is not a complete register of private SPVs or parallel entities.
Fund size, stages, and mandate
| Item | Supported finding | Interpretation and confidence |
| --- | --- | --- |
| Fund I legal vehicle / vintage | **ZAS Ventures Fund I, LP**, Delaware; entity organized **2021**; first sale **2023-07-07**. SEC amendment signed **2025-07-07** reports **$3,331,818 offered and sold**, **$0 remaining**, **39 investors**. [S3] | High confidence in issuer-reported offering facts. Approximately $3.33m is the fully sold offering reported then; it is not independently audited AUM or a cash-in-bank figure. Formation year and fundraising vintage differ. |
| Fund II legal vehicle / vintage | **ZAS Ventures Fund II, LP**, Delaware; entity organized **2025**; first sale **2026-02-14**. SEC Form D filed **2026-02-26** reports **$15,000,000 offered**, **$1,420,000 sold**, **$13,580,000 remaining**, **8 investors**. [S4] | High confidence in filing facts. $15m is an offering target, not final close. $1.42m is sold at filing, not an assertion of current October 2026 size. No later close verified. |
| Additional fund chronology | Private Equity International lists Fund I closed July 2025 and Fund II open March 2026; sizes are behind its access controls. [S5] | Broad chronology supports filings; March database open date differs from February first sale/filing. Prefer explicit SEC dates for fundraising events. |
| Total AUM | Not verified. | Do not add a target to sold amounts or treat deployment totals as AUM. |
| Public deployment metric | Firm homepage says **$2m+ invested since launch**. [S1] | Undated deployment claim, not fund size. Separate official ZAS Angels site also says **$2m+ deployed since its 2023 launch**. [S16] Attribution/overlap unknown. |
| Initial investment stage | **Pre-seed** is expressly stated by managing partner in February 2025 interview; homepage describes earliest-stage investment and follow-on capacity. [S1, S6] | Strong strategy evidence. Seed participation also appears historically; no formal full later-stage mandate verified. |
| Current public checks | Firm homepage **$50k–$200k**, structured with SAFEs. Related ZAS Group site **$50k–$100k**. [S1, S17] | Conflicting undated first-party ranges; retain both with provenance. |
| Dated fund vs syndicate checks | February 2025 interview: fund **$50k–$100k**, syndicate **$100k–$1m**, possible fund follow-ons. [S6] | Distinguish vehicles. September 2026 Robutler funding of **$400k across Fund I and Fund II** demonstrates an actual investment larger than homepage's generic range. [S15] |
| Geography / technology | Homepage emphasizes Ukrainian/CEE founders succeeding in North America. February 2025 interview considers hardware cautiously. [S1, S6] | Sector-generalist early-stage firm with verified scientific/technical portfolio, not exclusively hardware/neurotech. |
Formation year **2021** is supported for Fund I by SEC. Reporting places the firm's official public launch in **September 2023** (AIN, 2023-09-22), so a later reviewer should distinguish legal formation from launch rather than overwrite one with the other. The 2023 launch report excluded hardware; later evidence above suggests an evolving approach. September 2026 reporting describes AI, SaaS and robotics focus. This is potentially evolving strategy, not proof that old and new accounts are simultaneously wrong. [S3, S6, S18, S15]
Source register
All URLs accessed **2026-10-06**. “Undated” means no publication date established; webpage footer/crawl dates are not used as publication dates. Sources are paraphrased; a publication's repetition of investor/company claims is not independent technical validation.
| Ref | Source / publication date | URL |
| --- | --- | --- |
| S1 | ZAS official homepage — undated | https://zas.ventures/ |
| S2 | ZAS official portfolio — undated | https://zas.ventures/portfolio/ |
| S3 | SEC issuer Form D/A, Fund I — signed 2025-07-07 | https://www.sec.gov/Archives/edgar/data/1900299/000190029925000002/xslFormDX01/primary_doc.xml |
| S4 | SEC issuer Form D, Fund II — filed/signed 2026-02-26 | https://www.sec.gov/Archives/edgar/data/2112253/000211225326000001/xslFormDX01/primary_doc.xml |
| S5 | Private Equity International institution profile — undated; sizes restricted | https://www.privateequityinternational.com/institution-profiles/zas-ventures.html |
| S6 | Scroll managing-partner interview — 2025-02-05 | https://scroll.media/2025/02/05/chek-fondu-do-100-000-syndykatu-do-1-mln-andrij-zinchuk-pro-zas-ventures/ |
| S7 | ZAS official S.Lab profile — undated | https://zas.ventures/portfolio/slab |
| S8 | S.Lab official site — undated; former ilab-s.com redirects here | https://s-lab.bio/ |
| S9 | AIN founder profile, S.Lab — 2026-01-08; search-index text available | https://en.ain.ua/2026/01/08/startup-of-the-day-slab/ |
| S10 | ZAS official ReSpindle profile — undated | https://zas.ventures/portfolio/respindle |
| S11 | ReSpindle official site — undated | https://respindle.com/ |
| S12 | Scroll Gamow Tech funding report — 2025-10-20 | https://scroll.media/2025/10/20/zas-ventures-gamow-tech/ |
| S13 | ZAS official CheckEye profile — undated | https://zas.ventures/portfolio/checkeye |
| S14 | ZAS official Mantis profile — undated; unrelated cloud-cost feature bullets appear to be a copy error | https://zas.ventures/portfolio/mantis-analytics |
| S15 | Tech.eu, Robutler funding — 2026-09-10 | https://tech.eu/2026/09/10/robutler-raises-400k-from-zas-ventures-to-build-the-youtube-of-software/ |
| S16 | ZAS Angels official homepage / portfolio — undated | https://zasangels.com/ |
| S17 | ZAS Group official homepage — undated | https://zasv.group/ |
| S18 | AIN official-launch report — 2023-09-22; English direct fetch 403, search-index text available; Ukrainian counterpart indexed | https://en.ain.ua/2023/09/22/ukrainian-vc-firm-zas-ventures-announces-its-official-launch/ ; https://ain.ua/2023/09/22/zas-ventures/ |
| S19 | Ukraine Digital State government CheckEye report — 2025-10-21 | https://digitalstate.gov.ua/uk/news/tech/checkeye-ukrayinskyy-healthtech-startap-zaluchyv-700-000-investytsiy-ta-vykhodyt-na-rynok-yes |
| S20 | Scroll founder interview / CheckEye total clarification — 2025-10-23; search-index text | https://scroll.media/2025/10/23/checkeye-blitz/ |
| S21 | AIN initial Mantis transaction — 2024-03-26; search-index text | https://en.ain.ua/2024/03/26/zas-ventures-invests-50000-mantis-analytics/ |
| S22 | Vestbee Mantis pre-seed report — 2024-04-02; search-index text | https://www.vestbee.com/insights/articles/ukrainian-ai-startup-mantis-analytics-secures-50k-from-zas-ventures |
| S23 | Mantis founder Anton Tarasyuk and embedded company announcement — undated post; search-index text | https://www.linkedin.com/posts/antontarasyuk_zas-ventures-%D0%B7%D0%BD%D0%BE%D0%B2%D1%83-%D1%96%D0%BD%D0%B2%D0%B5%D1%81%D1%82%D1%83%D0%B2%D0%B0%D0%B2-50-000-%D0%B2-mantis-activity-7244353367571906560-Pyi9 |
| S24 | ZAS official Robutler $400k post — undated; search-index text | https://www.linkedin.com/posts/zas-ventures_zas-ventures-robutler-activity-7504155244495388672-aXuV |
| S25 | ZAS Q1 newsletter — 2025-04-10; directly read | https://www.linkedin.com/pulse/zas-pulse-q1-2025-zas-ventures-cctkf |
| S26 | ZAS official Aspichi profile — undated | https://zas.ventures/portfolio/aspichi |
| S27 | Aspichi Luminify official site — undated | https://luminify.aspichi.com/ |
| S28 | TechCrunch Ukraine defense-tech roundup — 2025-02-24; index-accessed | https://techcrunch.com/2025/02/24/three-years-on-europe-looks-to-ukraine-for-the-future-of-defense-tech/ |
| S29 | InVenture CheckEye report / roadmap — 2025-10-22; secondary | https://inventure.com.ua/uk/news/ukraine/ukrayinskij-startap-checkeye-zaluchiv-dollar700-000-za-tri-roki-j-vihodit-na-rinok-yes |
| S30 | NFX Signal discovery homepage — undated; no identifiable matching profile located | https://signal.nfx.com/ |
Funds recorded in Adex after this review:
| Fund | Disclosed amount | Announcement / filing date |
| --- | --- | --- |
| ZAS Ventures Fund I, LP | Undisclosed / unverified | 2025-07-07 |
| ZAS Ventures Fund II, LP | Undisclosed / unverified | 2026-02-26 | SHOW MORE
team@apexlogos.ai · 13 hours ago
team@apexlogos.ai · 13 hours ago
Match research 2026-10-06 / ZASVentures / sha256:14d372c506ab2f8db282dc90455fbb2ca4aaa33c26434d47136efc33104d814c / part 2 of 3
Imported completed research. Baseline Adex/Signal statements describe prior state, not independent verification. Retain cited attribution, date, currency and classification caveats.
| **Mantis Analytics** | Applied AI for information-risk/disinformation monitoring; possible deep-tech exposure. Evidence establishes AI product/application, not necessarily novel foundational AI IP. | Initial **$50k** ZAS investment concluded **December 2023**, announced **2024-03-26**; Vestbee calls it **pre-seed**. Founder later confirms another **$50k**, **$100k total from ZAS**, on an undated LinkedIn post. | Official firm [S14]; AIN **2024-03-26** [S21]; Vestbee **2024-04-02** [S22]; founder primary [S23]. |
| **Robutler** | Research-based AI infrastructure candidate: agent discovery/trust/messaging; reporting mentions patent applications, TrustFlow research and open protocols. Scientific novelty still requires review; not ordinary SaaS automatically labeled deep tech. | **$400k from ZAS Fund I and Fund II**, reported **2026-09-10**. First institutional check; article does not formally name round stage. Firm official post confirms $400k. Missing from the 14-company homepage portfolio inspected. | Tech.eu **2026-09-10** [S15]; official firm post [S24]. |
Other baseline holdings include **DrugCards** (AI pharmacovigilance), **Stack Booster** (AI infrastructure tooling), and several general SaaS platforms. Their official listing alone is insufficient to classify them as deep tech, so this file does not inflate the category. [S2]
## Neurotech and adjacent investments
**No verified neurotech investment found in the sources checked.** This is an evidence limitation, not a claim that ZAS has never invested in the category. Searches included the firm with `neurotech`, `neurotechnology`, `brain`, and `BCI`, plus review of the official portfolio and the most relevant investees.
**Aspichi / Luminify — verified investment, neurotech-adjacent.** ZAS's official **Q1 newsletter published 2025-04-10** expressly says Aspichi raised from ZAS Ventures. Its official portfolio page describes AI-powered immersive VR mental-health therapy. Luminify's official site describes VR intervention for PTSD, anxiety and stress. This establishes mental-health software/VR exposure, but the sources reviewed do not establish neural recording, BCI, electrical neuromodulation or direct brain-device technology. Amount/stage/exact ZAS transaction date remain unknown. [S25–S27]
TechCrunch **2025-02-24** also names ZAS among Aspichi's funders; firm-level allocation remains undisclosed. [S28]
**CheckEye** is retinal diagnostics, not automatically neurotech. Secondary reporting mentions neurodegenerative-condition screening on its roadmap, but this is not proof of a current neural product or a separate neurotech investment. **ReSpindle** is reproductive medicine. **ComeBack Mobility** is IoT crutch rehabilitation and appears on **ZAS Angels'** official portfolio; do not transfer it to this fund or label it neural rehabilitation without further evidence. [S13, S16, S29]
## Conflicts, missing evidence, and later Adex review notes
1. Preserve **exact firm ID `ZASVentures`**. Do not conflate with **Zaz Ventures** (grant advisory) or **Z Venture Capital** (different firm), which appear in broad searches.
2. Fund-size evidence now exists, but use separate fund records/claims: Fund I $3,331,818 fully sold at July 2025 filing; Fund II $15m offering target and $1.42m sold at February 2026 filing. Check for newer SEC amendments or a dated close announcement before updating current totals.
3. Preserve the $50k–$200k homepage claim alongside the dated $50k–$100k fund range and $100k–$1m syndicate range. Robutler's $400k combined-fund transaction is an exception/historical check, not a new universal minimum.
4. S.Lab appears under both fund and syndicate; ComeBack Mobility is verified to ZAS Angels. Avoid merging the entities or counting all angel deals as ZAS Ventures fund investments. [S6, S16]
5. **ReSpindle ↔ Gamow Tech** needs company identity/legal-name review before changing any Adex company ID. €2.4m is valuation, not raised capital.
6. Aspichi is the strongest mental-health adjacent case, but a direct neurotech label remains unsupported. CheckEye's brain-disease roadmap is not verified current capability.
7. Portfolio dates, check sizes and round stages are still missing for S.Lab, Aspichi and CheckEye. Generic firm-stage focus must not populate company-specific rounds. Mantis initial agreement month differs from announcement date; record both explicitly.
8. CheckEye $700k versus $750k is an apparent reporting correction/expanded total; neither is ZAS investment size. Investee website https://check-eye.com/ and its www variant failed during access; technology is supported by the accessible firm page and dated government/reporting.
9. ReSpindle's current official site claims **Class I MDR / CE mark**, whereas October 2025 reporting said preparation for CE. Treat as possible subsequent progress; compliance/efficacy claims were not independently verified. [S11–S12]
10. Signal profile unresolved. Re-run discovery using name variants/connected account if useful; no Signal facts should be inserted based on guessing a URL.
11. The inspected official portfolio may lag newer transactions (Robutler), and undisclosed investments may exist. This is a researched shortlist with explicit evidence, not a complete transaction audit.
## Source register
All URLs accessed **2026-10-06**. “Undated” means no publication date established; webpage footer/crawl dates are not used as publication dates. Sources are paraphrased; a publication's repetition of investor/company claims is not independent technical validation.
| Ref | Source / publication date | URL |
| --- | --- | --- |
| S1 | ZAS official homepage — undated | https://zas.ventures/ |
| S2 | ZAS official portfolio — undated | https://zas.ventures/portfolio/ |
| S3 | SEC issuer Form D/A, Fund I — signed 2025-07-07 | https://www.sec.gov/Archives/edgar/data/1900299/000190029925000002/xslFormDX01/primary_doc.xml |
| S4 | SEC issuer Form D, Fund II — filed/signed 2026-02-26 | https://www.sec.gov/Archives/edgar/data/2112253/000211225326000001/xslFormDX01/primary_doc.xml |
| S5 | Private Equity International institution profile — undated; sizes restricted | https://www.privateequityinternational.com/institution-profiles/zas-ventures.html |
| S6 | Scroll managing-partner interview — 2025-02-05 | https://scroll.media/2025/02/05/chek-fondu-do-100-000-syndykatu-do-1-mln-andrij-zinchuk-pro-zas-ventures/ |
| S7 | ZAS official S.Lab profile — undated | https://zas.ventures/portfolio/slab |
| S8 | S.Lab official site — undated; former ilab-s.com redirects here | https://s-lab.bio/ |
| S9 | AIN founder profile, S.Lab — 2026-01-08; search-index text available | https://en.ain.ua/2026/01/08/startup-of-the-day-slab/ |
| S10 | ZAS official ReSpindle profile — undated | https://zas.ventures/portfolio/respindle |
| S11 | ReSpindle official site — undated | https://respindle.com/ |
| S12 | Scroll Gamow Tech funding report — 2025-10-20 | https://scroll.media/2025/10/20/zas-ventures-gamow-tech/ |
| S13 | ZAS official CheckEye profile — undated | https://zas.ventures/portfolio/checkeye |
| S14 | ZAS official Mantis profile — undated; unrelated cloud-cost feature bullets appear to be a copy error | https://zas.ventures/portfolio/mantis-analytics |
| S15 | Tech.eu, Robutler funding — 2026-09-10 | https://tech.eu/2026/09/10/robutler-raises-400k-from-zas-ventures-to-build-the-youtube-of-software/ |
| S16 | ZAS Angels official homepage / portfolio — undated | https://zasangels.com/ |
| S17 | ZAS Group official homepage — undated | https://zasv.group/ |
| S18 | AIN official-launch report — 2023-09-22; English direct fetch 403, search-index text available; Ukrainian counterpart indexed | https://en.ain.ua/2023/09/22/ukrainian-vc-firm-zas-ventures-announces-its-official-launch/ ; https://ain.ua/2023/09/22/zas-ventures/ |
| S19 | Ukraine Digital State government CheckEye report — 2025-10-21 | https://digitalstate.gov.ua/uk/news/tech/checkeye-ukrayinskyy-healthtech-startap-zaluchyv-700-000-investytsiy-ta-vykhodyt-na-rynok-yes |
| S20 | Scroll founder interview / CheckEye total clarification — 2025-10-23; search-index text | https://scroll.media/2025/10/23/checkeye-blitz/ |
| S21 | AIN initial Mantis transaction — 2024-03-26; search-index text | https://en.ain.ua/2024/03/26/zas-ventures-invests-50000-mantis-analytics/ |
| S22 | Vestbee Mantis pre-seed report — 2024-04-02; search-index text | https://www.vestbee.com/insights/articles/ukrainian-ai-startup-mantis-analytics-secures-50k-from-zas-ventures | SHOW MORE
team@apexlogos.ai · 13 hours ago
Match research 2026-10-06 / ZASVentures / sha256:14d372c506ab2f8db282dc90455fbb2ca4aaa33c26434d47136efc33104d814c / part 1 of 3
Imported completed research. Baseline Adex/Signal statements describe prior state, not independent verification. Retain cited attribution, date, currency and classification caveats.
# ZAS Ventures
**Exact Adex ID:** `ZASVentures`
**Adex webpage:** https://adex.page/firms/ZASVentures
**Research date / source access date:** 2026-10-06
**Status:** Completed focused public-source research; unresolved items are explicit below. Research only: no Adex or database updates.
ZAS Ventures has credible previous deep-tech exposure through **S.Lab** (mycelium materials) and **Gamow Tech / ReSpindle** (reproductive-medicine computer vision), plus applied-AI candidates **Mantis Analytics**, **CheckEye**, and **Robutler**. **Aspichi / Luminify** is a verified portfolio investment in VR mental-health therapy, classified here as neurotech-adjacent. No verified direct neurotech investment found in the sources checked. SEC filings establish Fund I's approximately **$3.33 million fully sold offering** and Fund II's **$15 million offering target with $1.42 million sold as of February 2026**; the latter must not be represented as a $15 million closed fund. [S3–S4, S7–S15]
## Starting evidence: existing Adex and NFX Signal
The parent retrieved the existing record through read-only Adex MCP `Search` (`_type: Org`, term `ZAS Ventures`, labels `[Match]`) at **2026-10-06T19:28:50.822Z**. I read the saved exact-ID result first: `data/research/_sources/ZASVentures.adex.json`.
- Existing description: Ukrainian-American early-stage firm, founded 2021, investing $50,000–$200,000 in Ukrainian and CEE-founded startups expanding into US/EU markets. Structured `founded`, `checkMin`, `checkMax`, and `sweetSpot` fields are null; no fund-size value is supplied.
- Existing provenance: https://zas.ventures/ and https://zas.ventures/portfolio/ , accessed 2026-09-14; existing claim is firm-sourced, not independently verified by the baseline.
- Existing portfolio investment claims: **S.Lab** (Adex company ID `Slab`), **CloudAvocado**, **Mantis Analytics**, **Aspichi**, **DrugCards**, **Every Health**, **CROWN Procurement**, **Triberry**, **Unstuck Engine**, **Stack Booster**, **Ranking Copilot**, **Input Soft**, **CheckEye**, **ReSpindle**. All have unknown dates, amounts and stages in the record. Current official portfolio still lists all 14. [S2]
- Existing people/roles: Andriy Zinchuk (Founding Partner), Artem Volkhonskyi (Tech and Operations Leader), Olga Baranets (Venture Partner and Head of Portfolio), Dave Matli and Sergey Kudryashov (Venture Partners), Dmytro Derkach (Investment Analyst), Maksymilian Kusmierek (Venture Partner). These are baseline records, not a fresh employment audit.
- **NFX Signal:** No Signal URL in Adex. Searches on 2026-10-06 for `site:signal.nfx.com "ZAS" "Ventures"`, `"Andriy Zinchuk"`, `"Zinchuk"`, `"Dave Matli"`, and combined `"ZAS Ventures" OR "Andrew Zinchuk" OR "Matli"` did not yield an identifiable firm/team profile. Signal's homepage was directly accessible at https://signal.nfx.com/ , but no matching profile was located. Thus no Signal fund/stage/check claims are used. Profile absence is unproven; unindexed or account-only profiles may exist.
## Fund size, stages, and mandate
| Item | Supported finding | Interpretation and confidence |
| --- | --- | --- |
| Fund I legal vehicle / vintage | **ZAS Ventures Fund I, LP**, Delaware; entity organized **2021**; first sale **2023-07-07**. SEC amendment signed **2025-07-07** reports **$3,331,818 offered and sold**, **$0 remaining**, **39 investors**. [S3] | High confidence in issuer-reported offering facts. Approximately $3.33m is the fully sold offering reported then; it is not independently audited AUM or a cash-in-bank figure. Formation year and fundraising vintage differ. |
| Fund II legal vehicle / vintage | **ZAS Ventures Fund II, LP**, Delaware; entity organized **2025**; first sale **2026-02-14**. SEC Form D filed **2026-02-26** reports **$15,000,000 offered**, **$1,420,000 sold**, **$13,580,000 remaining**, **8 investors**. [S4] | High confidence in filing facts. $15m is an offering target, not final close. $1.42m is sold at filing, not an assertion of current October 2026 size. No later close verified. |
| Additional fund chronology | Private Equity International lists Fund I closed July 2025 and Fund II open March 2026; sizes are behind its access controls. [S5] | Broad chronology supports filings; March database open date differs from February first sale/filing. Prefer explicit SEC dates for fundraising events. |
| Total AUM | Not verified. | Do not add a target to sold amounts or treat deployment totals as AUM. |
| Public deployment metric | Firm homepage says **$2m+ invested since launch**. [S1] | Undated deployment claim, not fund size. Separate official ZAS Angels site also says **$2m+ deployed since its 2023 launch**. [S16] Attribution/overlap unknown. |
| Initial investment stage | **Pre-seed** is expressly stated by managing partner in February 2025 interview; homepage describes earliest-stage investment and follow-on capacity. [S1, S6] | Strong strategy evidence. Seed participation also appears historically; no formal full later-stage mandate verified. |
| Current public checks | Firm homepage **$50k–$200k**, structured with SAFEs. Related ZAS Group site **$50k–$100k**. [S1, S17] | Conflicting undated first-party ranges; retain both with provenance. |
| Dated fund vs syndicate checks | February 2025 interview: fund **$50k–$100k**, syndicate **$100k–$1m**, possible fund follow-ons. [S6] | Distinguish vehicles. September 2026 Robutler funding of **$400k across Fund I and Fund II** demonstrates an actual investment larger than homepage's generic range. [S15] |
| Geography / technology | Homepage emphasizes Ukrainian/CEE founders succeeding in North America. February 2025 interview considers hardware cautiously. [S1, S6] | Sector-generalist early-stage firm with verified scientific/technical portfolio, not exclusively hardware/neurotech. |
Formation year **2021** is supported for Fund I by SEC. Reporting places the firm's official public launch in **September 2023** (AIN, 2023-09-22), so a later reviewer should distinguish legal formation from launch rather than overwrite one with the other. The 2023 launch report excluded hardware; later evidence above suggests an evolving approach. September 2026 reporting describes AI, SaaS and robotics focus. This is potentially evolving strategy, not proof that old and new accounts are simultaneously wrong. [S3, S6, S18, S15]
## Previous deep-tech investments, with attribution
Classification is my assessment from the described technology; verified investment does not independently prove technical efficacy or deep-tech status. Specific fund allocation is unknown unless stated. Firm portfolio inclusion is a first-party investment claim; dated reporting adds transaction detail.
| Company | Technology rationale / category | ZAS attribution, amount, stage and date | Supporting evidence |
| --- | --- | --- | --- |
| **S.Lab** (`Slab` in Adex) | Strong deep-tech fit: biological materials from mushroom mycelium and agricultural waste; company describes automated manufacturing and a robotic shaping process. | Official ZAS portfolio company. AIN founder profile identifies ZAS Ventures among investors; over €1.3m cumulative development funding mixes grants, accelerators, VCs and angels, not ZAS's check. ZAS Angels also invested; fund and syndicate should be distinguished. Exact ZAS round/date/check unverified here. | Official firm [S7]; investee [S8]; AIN **2026-01-08** [S9]; syndicate official [S16]. |
| **Gamow Tech / ReSpindle** (`ReSpindle` in Adex) | Strong medical deep-tech fit: computer vision evaluates oocyte spindle morphology during IVF. Science-linked image assessment; reproductive medicine, not neurotech. | ZAS investment reported **2025-10-20**; **€2.4m company valuation**, investment amount undisclosed. Stage not expressly given. ReSpindle is product/company-facing brand; report identifies Gamow Tech as developing it. | Official firm [S10]; investee [S11]; Scroll **2025-10-20** [S12]. |
| **CheckEye** | Medical-AI candidate: ML on retinal/fundus photos detects diabetic retinopathy. Requires clinical validation; classification as deep tech is plausible rather than established by a general AI label. | Listed officially by ZAS. ZAS check, stage and date not found. Government **2025-10-21** reports **$700k cumulative funding over 3+ years**, but does not attribute that sum to ZAS. Scroll **2025-10-23** reports company clarification of **$750k**, combining private capital and support/grants. | Official firm [S13]; government [S19]; Scroll [S20]. | SHOW MORE
team@apexlogos.ai · 23 days ago
MATCH 
Slab